Martindale Pharma shortlisted at EB Awards 2014

18.03.2014

as a finalist at this year’s Employee Benefits Awards in the category best financial education strategy.

Making it through to the finals recognises the work Secondsight and Martindale Pharma undertook on making changes to the company’s pension scheme and how this was effectively communicated to employees; resulting in 73% of employees actively making choices about their pension.

To view the full shortlist, please click here.

The winners will be announced at an awards ceremony in London on the 27th June.

Similar reading

Press release Foster Denovo partners with Redmill Advance 3.04.2024

Press release Roger Brosch discusses why no one in advice benefits from social media ‘mudslinging’ 22.03.2024

Press release Foster Denovo’s Roger Brosch profile: Growth trajectory 11.03.2024

Foster Denovo Limited is registered in England and Wales Reg No. 05970987. Registered office: Ruxley House, 2 Hamm Moor Lane, Addlestone, Surrey, KT15 2SA. Foster Denovo Limited is authorised and regulated by the Financial Conduct Authority. FCA Reg No. 462728. You can check this by visiting the Financial Services Register on the Financial Conduct Authority’s website: http://www.fca.org.uk/. The Financial Conduct Authority does not regulate taxation and trust advice and some aspects of buy-to-let mortgages. Some of the fees we charge may be subject to VAT, but we’ll let you know in advance if this is applicable. VAT No. 904 450 842. The guidance and/or advice contained within the website is subject to the UK regulatory regime and is therefore primarily targeted at customers in the UK. If you click on a link and leave the Foster Denovo website, we cannot be held responsible for the content of the external website.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Martindale Pharma shortlisted at EB Awards 2014

Similar reading

Sign up for the latest financial news